|
|
|
Volumn 9, Issue 2 SUPPL. 1, 1999, Pages 102-107
|
|
Paclitaxel and concurrent radiotherapy in locally advanced non-small cell lung cancer: The Canadian experience
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PACLITAXEL;
ADVANCED CANCER;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
LYMPHOCYTOPENIA;
MALE;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIOSENSITIZATION;
REVIEW;
SKIN TOXICITY;
TREATMENT OUTCOME;
CANADA;
CARCINOMA, NON-SMALL-CELL LUNG;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
LUNG NEOPLASMS;
MALE;
PACLITAXEL;
RADIATION-SENSITIZING AGENTS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 0032948193
PISSN: 10534296
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (16)
|
|
References (16)
|
